XIFAXAN Side Effects

7003652-5 | Atrial Fibrillation, Blood Thyroid Stimulating Hormone Increased, Convulsion, Specific Gravity Urine Increased
on Sep 15, 2010 Female patient from UNITED STATES , 68 years of age, weighting 214.0 lb, was diagnosed with laboratory test abnormal and was treated with Xifaxan (View Usage). Patient experienced the following unwanted or unexpected effects: atrial fibrillation (What is atrial fibrillation?), blood thyroid stimulating hormone increased, convulsion, specific gravity urine increased. Xifaxan dosage: 1650 Mg (550 Mg, 3 In 1 D), Oral. During the same period patient was treated with BENICAR HCT (View Benicar Hct Review and Benicar Hct Label ), MULTI VITAMIN (View Multi-vitamin Review and Multi-vitamin Label ), FISH OIL (View Fish Oil Review and Fish Oil Label ), ASPIRIN (View Aspirin Review and Aspirin Label ). Patient was hospitalized.

6936130-X | Asthenia, Dehydration, Dysphagia, Gastrointestinal Candidiasis, Hypophagia, Oesophageal Candidiasis, Scar
Patient was taking Xifaxan (View Usage). Patient had the following side effects: asthenia, dehydration, dysphagia, gastrointestinal candidiasis, hypophagia, oesophageal candidiasis, scar (What is scar?) on Aug 19, 2010 from UNITED STATES Additional patient health information: Female patient , 47 years of age, weighting 152.0 lb, was diagnosed with abdominal distension, constipation (What is constipation?), irritable bowel syndrome (What is irritable bowel syndrome?), nausea (What is nausea?) and. Xifaxan dosage: 550 Mmg. Tab Let 3 Day Po. During the same period patient was treated with FLUCONAZOLE (View Fluconazole Review and Fluconazole Label ). Patient was hospitalized and became disabled.

6905410-6 | Atrial Fibrillation, Blood Thyroid Stimulating Hormone Increased, Bruxism, Confusional State, Convulsion, Memory Impairment, Specific Gravity Urine Increased, Staring, Tremor
Adverse event was reported on Jul 20, 2010 by a Female patient taking Xifaxan (View Usage) (Dosage: 1650 Mg (550 Mg, 3 In 1 D), Oral) . Location: UNITED STATES , 68 years of age, weighting 214.0 lb, After Xifaxan was administered, patient had the following side effects: atrial fibrillation (What is atrial fibrillation?), blood thyroid stimulating hormone increased, bruxism, confusional state, convulsion, memory impairment, specific gravity urine increased, staring, tremor. During the same period patient was treated with BENICAR HCT (View Benicar Hct Review and Benicar Hct Label ), MULTI VITAMIN (View Multi-vitamin Review and Multi-vitamin Label ), FISH OIL (View Fish Oil Review and Fish Oil Label ), ASPIRIN (View Aspirin Review and Aspirin Label ). Patient was hospitalized.

6872421-9 | Asthenia, Blood Calcium Decreased, Blood Sodium Decreased, Dehydration, Diarrhoea, Fatigue, Hypokalaemia, Hypomagnesaemia, Muscle Spasms
on Jul 15, 2010 Male patient from UNITED STATES , 42 years of age, weighting 153.0 lb, was diagnosed with crohn's disease (What is crohn's disease?) and was treated with Xifaxan (View Usage). Patient experienced the following unwanted or unexpected effects: asthenia, blood calcium decreased, blood sodium decreased, dehydration, diarrhoea, fatigue, hypokalaemia, hypomagnesaemia, muscle spasms. Xifaxan dosage: 600 Mg (200 Mg, 3 In 1 D), Oral. During the same period patient was treated with REMICADE ((5 Mg/kg), Intravenous) (View Remicade Review and Remicade Label ), CIMZIA (14.2857 Mg (400 Mg, 1 In 4 Wk)) (View Cimzia Review and Cimzia Label ), NEXIUM (40 Mg (40 Mg, 1 In 1 D)) (View Nexium Review and Nexium Label ), QUESTRAN ((2 In 1 D)) (View Questran Review and Questran Label ), PEDIALYTE (View Pedialyte Review and Pedialyte Label ), IMODIUM (View Imodium Review and Imodium Label ), DIGESTIVE ADVANTAGE (View Digestive Advantage Review and Digestive Advantage Label ), LOMOTIL (View Lomotil Review and Lomotil Label ). Patient was hospitalized.


6831687-1 | Cholestasis, Liver Function Test Abnormal, Pneumonia
on Jul 02, 2010 Male patient from ITALY , 81 years of age, was treated with Xifaxan (View Usage). Patient had the following side effects: cholestasis, liver function test abnormal, pneumonia (What is pneumonia?). Xifaxan dosage: Oral. During the same period patient was treated with CLARITHROMYCIN (View Clarithromycin Review and Clarithromycin Label ), CEFOTAXIME SODIUM (View Cefotaxime Sodium Review and Cefotaxime Sodium Label ), DOXYCYCLINE (View Doxycycline Review and Doxycycline Label ), FLUCONAZOLE (View Fluconazole Review and Fluconazole Label ). Patient was hospitalized.

6767405-5 | Communication Disorder, Disturbance In Attention, Dizziness, Dysphemia, Eye Movement Disorder, Pallor, Social Avoidant Behaviour, Speech Disorder, Vision Blurred
Patient was taking Xifaxan (View Usage). After Xifaxan was administered, patient had the following side effects: communication disorder, disturbance in attention, dizziness (What is dizziness?), dysphemia, eye movement disorder, pallor, social avoidant behaviour, speech disorder, vision blurred on Jun 08, 2010 from UNITED STATES Additional patient health information: Female patient , 29 years of age, weighting 160.0 lb, was diagnosed with gastrointestinal bacterial infection and. Xifaxan dosage: 1200 Mg (400 Mg, 3 In 1 D), Oral.

6738074-5 | Oesophageal Varices Haemorrhage
Adverse event was reported on May 17, 2010 by a Male patient taking Xifaxan (View Usage) (Dosage: 1200 Mg (400 Mg, 3 In 1 D), Oral) was diagnosed with hepatic encephalopathy and. Location: UNITED STATES , 58 years of age, weighting 123.0 lb, Patient experienced the following unwanted or unexpected effects: oesophageal varices haemorrhage. During the same period patient was treated with LASIX (View Lasix Review and Lasix Label ), SPIRONOLACTONE (View Spironolactone Review and Spironolactone Label ). Patient was hospitalized and became disabled.

6736721-5 | Activities Of Daily Living Impaired, Disturbance In Attention, Dizziness, Dysphemia, Eye Movement Disorder, Feeling Abnormal, Frustration, Headache, Impaired Driving Ability
on May 20, 2010 Female patient from UNITED STATES , 29 years of age, weighting 160.0 lb, was diagnosed with irritable bowel syndrome (What is irritable bowel syndrome?) and was treated with Xifaxan (View Usage). Patient had the following side effects: activities of daily living impaired, disturbance in attention, dizziness (What is dizziness?), dysphemia, eye movement disorder, feeling abnormal, frustration, headache (What is headache?), impaired driving ability. Xifaxan dosage: 400mg Tid Po.

6733565-5 | Hepatic Failure, Renal Failure
on May 12, 2010 Male patient from UNITED STATES , weighting 130.0 lb, was diagnosed with infection (What is infection?), liver disorder, renal disorder and was treated with Xifaxan (View Usage). After Xifaxan was administered, patient had the following side effects: hepatic failure, renal failure. Xifaxan dosage: 200mg.

6695773-1 | Haemorrhage
Patient was taking Xifaxan (View Usage). Patient experienced the following unwanted or unexpected effects: haemorrhage on Apr 23, 2010 from UNITED STATES Additional patient health information: Female patient , 71 years of age, weighting 204.0 lb, was diagnosed with irritable bowel syndrome (What is irritable bowel syndrome?) and. Xifaxan dosage: 2 3xday Po.

6676800-4 | Anorectal Infection, Fungal Infection, Vulvovaginal Mycotic Infection
Adverse event was reported on Apr 09, 2010 by a Female patient taking Xifaxan (View Usage) (Dosage: 2 Tabs, 3 Times A Day Til Gone) was diagnosed with constipation (What is constipation?), flatulence and. Location: UNITED STATES , 69 years of age, weighting 143.0 lb, Patient had the following side effects: anorectal infection, fungal infection (What is fungal infection?), vulvovaginal mycotic infection.

6613147-6 | Blood Calcium Decreased, Blood Magnesium Decreased, Blood Potassium Decreased, Blood Sodium Decreased, Dehydration, Diarrhoea, Fatigue, Muscle Spasms, Renal Failure Acute
on Feb 22, 2010 Male patient from UNITED STATES , 42 years of age, weighting 153.0 lb, was diagnosed with crohn's disease (What is crohn's disease?) and was treated with Xifaxan (View Usage). After Xifaxan was administered, patient had the following side effects: blood calcium decreased, blood magnesium decreased, blood potassium decreased, blood sodium decreased, dehydration, diarrhoea, fatigue, muscle spasms, renal failure acute. Xifaxan dosage: 600 Mg (200 Mg, 3 In 1 D), Oral. During the same period patient was treated with REMICADE ((5 Mg/kg), Intravenous) (View Remicade Review and Remicade Label ), CIMZIA (14.2857 Mg (400 Mg, 1 In 4 Wk)) (View Cimzia Review and Cimzia Label ), NEXIUM (40 Mg (40 Mg, 1 In 1 D)) (View Nexium Review and Nexium Label ), QUESTRAN ((2 In 1 D)) (View Questran Review and Questran Label ), PEDIALYTE (View Pedialyte Review and Pedialyte Label ), IMODIUM (View Imodium Review and Imodium Label ), DIGESTIVE ADVANTAGE (View Digestive Advantage Review and Digestive Advantage Label ), LOMOTIL (View Lomotil Review and Lomotil Label ). Patient was hospitalized.

6455226-2 | Dehydration, Diarrhoea, Fatigue, Muscle Spasms, Renal Failure Acute
on Nov 13, 2009 Male patient from UNITED STATES , 42 years of age, weighting 153.0 lb, was diagnosed with crohn's disease (What is crohn's disease?) and was treated with Xifaxan (View Usage). Patient experienced the following unwanted or unexpected effects: dehydration, diarrhoea, fatigue, muscle spasms, renal failure acute. Xifaxan dosage: 600 Mg (200 Mg, 3 In 1 D), Oral. During the same period patient was treated with REMICADE ((5 Mg/kg), Intravenous) (View Remicade Review and Remicade Label ), CIMZIA (14.2857 Mg (400 Mg, 1 In 4 Wk)) (View Cimzia Review and Cimzia Label ), NEXIUM (40 Mg (40 Mg, 1 In 1d)) (View Nexium Review and Nexium Label ), QUESTRAN ((2 In 1 D)) (View Questran Review and Questran Label ), PEDIALYTE (View Pedialyte Review and Pedialyte Label ), IMODIUM (View Imodium Review and Imodium Label ), DIGESTIVE ADVANTAGE (View Digestive Advantage Review and Digestive Advantage Label ). Patient was hospitalized.

6390278-X | Herpes Zoster
Patient was taking Xifaxan (View Usage). Patient had the following side effects: herpes zoster on Sep 30, 2009 from UNITED STATES Additional patient health information: Female patient , 63 years of age, weighting 221.0 lb, was diagnosed with overgrowth bacterial, immunisation and. Xifaxan dosage: 1200 Mg (400 Mg, 3 In 1 D), Oral. During the same period patient was treated with ZOSTAVEX (View Zostavex Review and Zostavex Label ), LEXAPRO (View Lexapro Review and Lexapro Label ), RESTORIL (View Restoril Review and Restoril Label ). Patient was hospitalized and became disabled.

6369816-9 | Alanine Aminotransferase Increased, Alcohol Use, Alcohol Withdrawal Syndrome, Aspartate Aminotransferase Increased, Blood Amylase Increased, Blood Bilirubin Increased, Blood Chloride Decreased, Blood Glucose Increased, Blood Potassium Decreased
Adverse event was reported on Sep 02, 2009 by a Male patient taking Xifaxan (View Usage) (Dosage: 1650 Mg (550 Mg, 3 In 1 D) Per Oral) was diagnosed with irritable bowel syndrome (What is irritable bowel syndrome?) and. Location: UNITED STATES , 50 years of age, weighting 160.0 lb, After Xifaxan was administered, patient had the following side effects: alanine aminotransferase increased, alcohol use, alcohol withdrawal syndrome, aspartate aminotransferase increased, blood amylase increased, blood bilirubin increased, blood chloride decreased, blood glucose increased, blood potassium decreased. During the same period patient was treated with PROZAC (View Prozac Review and Prozac Label ), THIAMINE HCL (View Thiamine Hcl Review and Thiamine Hcl Label ), FOLATE (View Folate Review and Folate Label ). Patient was hospitalized.

6336819-X | Homicidal Ideation
on Aug 31, 2009 Female patient from UNITED STATES , 18 years of age, weighting 105.0 lb, was treated with Xifaxan (View Usage). Patient experienced the following unwanted or unexpected effects: homicidal ideation. Xifaxan dosage: 1 Tablets 3 Times A Day Po.

6215444-5 | Diarrhoea, Hypertension, Malaise, Muscle Spasms
on Jun 01, 2009 Female patient from UNITED STATES , 71 years of age, weighting 158.0 lb, was diagnosed with diarrhoea, gastrointestinal infection and was treated with Xifaxan (View Usage). Patient had the following side effects: diarrhoea, hypertension, malaise, muscle spasms. Xifaxan dosage: 400 Mg (200 Mg, 2 In 1 D), Oral.

6168590-9 | Gingival Bleeding, Thrombocytopenia
Patient was taking Xifaxan (View Usage). After Xifaxan was administered, patient had the following side effects: gingival bleeding, thrombocytopenia on Apr 21, 2009 from AUSTRIA Additional patient health information: Female patient , 55 years of age, was diagnosed with hepatic encephalopathy and. Xifaxan dosage: (2 In 1 D), Oral. Patient was hospitalized.

6055340-X | Abdominal Discomfort, Anorectal Discomfort, Condition Aggravated, Diarrhoea, Electrolyte Imbalance, Faecal Incontinence, Flatulence, Migraine, Nasal Discomfort
Adverse event was reported on Jan 19, 2009 by a Male patient taking Xifaxan (View Usage) (Dosage: 800 Mg (400 Mg, 2 In 1 D)) was diagnosed with colitis and. Location: UNITED STATES , 79 years of age, weighting 145.0 lb, Patient experienced the following unwanted or unexpected effects: abdominal discomfort, anorectal discomfort, condition aggravated, diarrhoea, electrolyte imbalance, faecal incontinence, flatulence, migraine (What is migraine?), nasal discomfort. During the same period patient was treated with ASACOL (View Asacol Review and Asacol Label ), FLAGYL (View Flagyl Review and Flagyl Label ), NUTRITIONAL SUPPLEMENTS (View Nutritional Supplements Review and Nutritional Supplements Label ).

6024218-X | Abdominal Discomfort, Diarrhoea, Electrolyte Imbalance, Faecal Incontinence, Flatulence, Nasal Discomfort, Rhinorrhoea, Scotoma, Sneezing
on Dec 22, 2008 Male patient from UNITED STATES , 79 years of age, weighting 145.0 lb, was diagnosed with colitis and was treated with Xifaxan (View Usage). Patient had the following side effects: abdominal discomfort, diarrhoea, electrolyte imbalance, faecal incontinence, flatulence, nasal discomfort, rhinorrhoea, scotoma, sneezing. Xifaxan dosage: 400 Mg (200 Mg, 2 In 1 D). During the same period patient was treated with ASACOL (View Asacol Review and Asacol Label ), FLAGYL (View Flagyl Review and Flagyl Label ), NUTRITIONAL SUPPLEMENTS (View Nutritional Supplements Review and Nutritional Supplements Label ).

6018776-9 | Asthenia, Diarrhoea, Faecal Incontinence, Head Injury, Hypophagia, Insomnia
on Dec 16, 2008 Female patient from UNITED STATES , 85 years of age, weighting 100.0 lb, was diagnosed with gastrointestinal bacterial infection, overgrowth bacterial and was treated with Xifaxan (View Usage). After Xifaxan was administered, patient had the following side effects: asthenia, diarrhoea, faecal incontinence, head injury, hypophagia, insomnia. Xifaxan dosage: For 7 Days Each Month (200 Mg, 3 In 1 D), Oral. During the same period patient was treated with PANCREATIC ENZYMES (View Pancreatic Enzymes Review and Pancreatic Enzymes Label ), TINCTURE OF OPIUM (View Tincture Of Opium Review and Tincture Of Opium Label ), LEVOTHYROXINE (View Levothyroxine Review and Levothyroxine Label ), DARBEPOETIN ALFA (View Darbepoetin Alfa Review and Darbepoetin Alfa Label ), METOPROLOL (View Metoprolol Review and Metoprolol Label ), LPERAMIDE (View Lperamide Review and Lperamide Label ), VICODIN (View Vicodin Review and Vicodin Label ).

5922266-9 | Cerebral Atrophy, Clostridium Difficile Colitis, Condition Aggravated, Encephalopathy, Peritonitis Bacterial
Patient was taking Xifaxan (View Usage). Patient experienced the following unwanted or unexpected effects: cerebral atrophy, clostridium difficile colitis, condition aggravated, encephalopathy, peritonitis bacterial on Oct 01, 2008 from UNITED STATES Additional patient health information: Female patient , 60 years of age, was diagnosed with hepatic encephalopathy and. Xifaxan dosage: 1100 Mg (550 Mg, 2 In 1 D), Oral. Patient was hospitalized and became disabled.

5816095-4 | Chest Pain, Pruritus
Adverse event was reported on Dec 14, 2007 by a Female patient taking Xifaxan (View Usage) (Dosage: 800 Mg (200 Mg,4 In 1 D),oral) was diagnosed with hepatic encephalopathy, prophylaxis and. Location: UNITED STATES , 57 years of age, weighting 130.0 lb, Patient had the following side effects: chest pain (What is chest pain?), pruritus.

5816092-9 | Arthralgia
on Sep 27, 2007 Male patient from UNITED STATES , 61 years of age, weighting 235.0 lb, was diagnosed with pouchitis and was treated with Xifaxan (View Usage). After Xifaxan was administered, patient had the following side effects: arthralgia. Xifaxan dosage: 1200 Mg (400 Mg,3 In 1 D),oral. During the same period patient was treated with ALLOPURINOL (View Allopurinol Review and Allopurinol Label ).

5717216-4 | Abdominal Pain, Deafness Unilateral, Diarrhoea, Middle Ear Effusion, Vertigo
on Apr 17, 2008 Male patient from UNITED STATES , 54 years of age, was diagnosed with diarrhoea infectious and was treated with Xifaxan (View Usage). Patient experienced the following unwanted or unexpected effects: abdominal pain (What is abdominal pain?), deafness unilateral, diarrhoea, middle ear effusion, vertigo. Xifaxan dosage: 600 Mg (200 Mg, 3 In 1 D), Oral. During the same period patient was treated with FLAGYL (View Flagyl Review and Flagyl Label ). Patient was hospitalized and became disabled.

5485454-4 | Dysphonia, Throat Tightness
Patient was taking Xifaxan (View Usage). Patient had the following side effects: dysphonia, throat tightness on Oct 10, 2007 from UNITED STATES Additional patient health information: Female patient , 54 years of age, weighting 116.0 lb, was diagnosed with pouchitis and. Xifaxan dosage: 1 Tablet.

5484940-0 | Eosinophil Count Increased, Suicidal Ideation
Adverse event was reported on Oct 04, 2007 by a Male patient taking Xifaxan (View Usage) (Dosage: 1600 Mg (400 Mg, 4 In 1 D), Oral) was diagnosed with hepatic encephalopathy and. Location: UNITED STATES , 51 years of age, After Xifaxan was administered, patient had the following side effects: eosinophil count increased, suicidal ideation. Patient was hospitalized.

5463111-8 | Anaemia, Malaise, Nephritis Interstitial, No Therapeutic Response, Renal Failure Acute, Vomiting
on Sep 18, 2007 Female patient from UNITED STATES , 67 years of age, weighting 135.0 lb, was diagnosed with gastrointestinal disorder, overgrowth bacterial and was treated with Xifaxan (View Usage). Patient experienced the following unwanted or unexpected effects: anaemia, malaise, nephritis interstitial, no therapeutic response, renal failure acute, vomiting. Xifaxan dosage: 3 Per Day To 1 Per For 2 Wks Declining Po. Patient was hospitalized and became disabled.

5420962-3 | Clostridium Difficile Colitis, Peritonitis
on Aug 08, 2007 Male patient from UNITED STATES , 47 years of age, was diagnosed with hepatic encephalopathy prophylaxis, peritonitis and was treated with Xifaxan (View Usage). Patient had the following side effects: clostridium difficile colitis, peritonitis. Xifaxan dosage: 1200 Mg (400 Mg, 3 In 1 D). During the same period patient was treated with ERTAPENEM (View Ertapenem Review and Ertapenem Label ).

5420961-1 | Abdominal Pain, Clostridium Difficile Colitis, Diarrhoea, Peritonitis
Patient was taking Xifaxan (View Usage). After Xifaxan was administered, patient had the following side effects: abdominal pain (What is abdominal pain?), clostridium difficile colitis, diarrhoea, peritonitis on Aug 08, 2007 from UNITED STATES Additional patient health information: Male patient , 62 years of age, was diagnosed with hepatic encephalopathy prophylaxis, peritonitis and. Xifaxan dosage: 1200 Mg (400 Mg, 3 In 1 D). During the same period patient was treated with CEFTRIAXONE (View Ceftriaxone Review and Ceftriaxone Label ), CIPROFLOXACIN (View Ciprofloxacin Review and Ciprofloxacin Label ).

5390813-4 | Dyspnoea, Myalgia, Myocarditis, Oedema Peripheral, Vomiting
Adverse event was reported on Jul 05, 2007 by a Female patient taking Xifaxan (View Usage) (Dosage: 400 Mg (200 Mg, 2 In 1 D), Oral) was diagnosed with intestinal obstruction and. Location: ITALY , child 12 years of age, weighting 70.55 lb, Patient experienced the following unwanted or unexpected effects: dyspnoea, myalgia, myocarditis, oedema peripheral, vomiting. Patient was hospitalized and became disabled.

5376541-X | Atrial Fibrillation, Dyspnoea, Ejection Fraction Decreased, Myalgia, Myocarditis, Oedema Peripheral, Vomiting
on Jun 22, 2007 Female patient from ITALY , child 12 years of age, weighting 70.55 lb, was diagnosed with intestinal obstruction and was treated with Xifaxan (View Usage). Patient had the following side effects: atrial fibrillation (What is atrial fibrillation?), dyspnoea, ejection fraction decreased, myalgia, myocarditis, oedema peripheral, vomiting. Xifaxan dosage: 400 Mg (200 Mg, 2 In 1 D), Oral. Patient was hospitalized and became disabled.

5372224-0 | International Normalised Ratio Decreased
on Mar 14, 2007 Female patient from UNITED STATES , 57 years of age, weighting 165.0 lb, was diagnosed with irritable bowel syndrome (What is irritable bowel syndrome?), thrombosis prophylaxis and was treated with Xifaxan (View Usage). After Xifaxan was administered, patient had the following side effects: international normalised ratio decreased. Xifaxan dosage: 800 Mg (400 Mg, 2 In 1 D), Oral. During the same period patient was treated with WARFARIN SODIUM (5-7.5 Mg, Oral) (View Warfarin Sodium Review and Warfarin Sodium Label ), VENLAFAXINE HCL (View Venlafaxine Hcl Review and Venlafaxine Hcl Label ), M.V.I. (View M.v.i. Review and M.v.i. Label ).

5372135-0 | Feeling Abnormal, Headache, Pubic Pain
Patient was taking Xifaxan (View Usage). Patient experienced the following unwanted or unexpected effects: feeling abnormal, headache (What is headache?), pubic pain on Mar 09, 2007 from UNITED STATES Additional patient health information: Female patient , 79 years of age, weighting 145.0 lb, was diagnosed with irritable bowel syndrome (What is irritable bowel syndrome?) and. Xifaxan dosage: 600 Mg (200 Mg, 1 In 8 Hr), Oral.

5372131-3 | Abdominal Pain
Adverse event was reported on Feb 26, 2007 by a Male patient taking Xifaxan (View Usage) (Dosage: Oral) was diagnosed with bacterial infection (What is bacterial infection?) and. Location: UNITED STATES , 56 years of age, Patient had the following side effects: abdominal pain (What is abdominal pain?). During the same period patient was treated with ZELNORM (View Zelnorm Review and Zelnorm Label ).

5372128-3 | Diarrhoea
on May 18, 2007 Female patient from UNITED STATES , 69 years of age, weighting 240.0 lb, was diagnosed with colitis ulcerative and was treated with Xifaxan (View Usage). After Xifaxan was administered, patient had the following side effects: diarrhoea. Xifaxan dosage: 600 Mg (200 Mg, 3 In 1 D), Oral. During the same period patient was treated with ESOMEPRAZOLE MAGNESIUM (View Esomeprazole Magnesium Review and Esomeprazole Magnesium Label ), LEVOTHYROXINE SODIUM (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ), DEXAMETHASONE 0.5MG TAB (View Dexamethasone 0.5mg Tab Review and Dexamethasone 0.5mg Tab Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), OLMESARTAN MEDOXOMIL (View Olmesartan Medoxomil Review and Olmesartan Medoxomil Label ).

5372127-1 | Nausea
on May 07, 2007 Male patient from UNITED STATES , 61 years of age, weighting 157.0 lb, was diagnosed with irritable bowel syndrome (What is irritable bowel syndrome?) and was treated with Xifaxan (View Usage). Patient experienced the following unwanted or unexpected effects: nausea (What is nausea?). Xifaxan dosage: 1200 Mg (400 Mg, 3 In 1 D), Oral. During the same period patient was treated with PREGABALIN (View Pregabalin Review and Pregabalin Label ).

5372112-X | Diarrhoea, Hypersensitivity, Rash Pruritic
Patient was taking Xifaxan (View Usage). Patient had the following side effects: diarrhoea, hypersensitivity, rash pruritic on May 22, 2007 from UNITED STATES Additional patient health information: Female patient , 75 years of age, weighting 129.0 lb, was diagnosed with irritable bowel syndrome (What is irritable bowel syndrome?) and. Xifaxan dosage: 600 Mg (200 Mg, 3 In 1 D), Oral.

5372106-4 | Tongue Discolouration
Adverse event was reported on May 21, 2007 by a Female patient taking Xifaxan (View Usage) (Dosage: 400 Mg (200 Mg, 2 In 1 D), Oral) was diagnosed with hepatic encephalopathy and. Location: UNITED STATES , 62 years of age, After Xifaxan was administered, patient had the following side effects: tongue discolouration.

5372105-2 | Disturbance In Attention, Dry Mouth, Insomnia, Lip Dry, Nasal Congestion, Weight Decreased
on May 14, 2007 Female patient from UNITED STATES , 64 years of age, weighting 131.0 lb, was diagnosed with diarrhoea and was treated with Xifaxan (View Usage). Patient experienced the following unwanted or unexpected effects: disturbance in attention, dry mouth, insomnia, lip dry, nasal congestion, weight decreased. Xifaxan dosage: 1200 Mg (400 Mg, 3 In 1 D), Oral. During the same period patient was treated with DIAZEPAM (View Diazepam Review and Diazepam Label ), TORSEMIDE (View Torsemide Review and Torsemide Label ), POTASSIUM IODIDE (View Potassium Iodide Review and Potassium Iodide Label ), BUDESONIDE (View Budesonide Review and Budesonide Label ), MESALAZINE (View Mesalazine Review and Mesalazine Label ).

5372089-7 | Amnesia, Dizziness, Headache
on Apr 09, 2007 Female patient from UNITED STATES , 57 years of age, was diagnosed with gastric disorder and was treated with Xifaxan (View Usage). Patient had the following side effects: amnesia, dizziness (What is dizziness?), headache (What is headache?). Xifaxan dosage: 1200 Mg (400 Mg, 3 In 1 D), Oral. During the same period patient was treated with CIMETIDINE HCL (View Cimetidine Hcl Review and Cimetidine Hcl Label ), LORAZEPAM (View Lorazepam Review and Lorazepam Label ), HYDROCORTISONE (SUPPOSITORY) (View Hydrocortisone (suppository) Review and Hydrocortisone (suppository) Label ).

5372088-5 | Abdominal Pain, Headache, Tetany
Patient was taking Xifaxan (View Usage). After Xifaxan was administered, patient had the following side effects: abdominal pain (What is abdominal pain?), headache (What is headache?), tetany on May 01, 2007 from UNITED STATES Additional patient health information: Female patient , 47 years of age, weighting 110.0 lb, was diagnosed with colitis and. Xifaxan dosage: 800 Mg (400 Mg, 2 In 1 D), Oral.

5290186-1 | Back Pain, Condition Aggravated
Adverse event was reported on Mar 27, 2007 by a Female patient taking Xifaxan (View Usage) (Dosage: 1200 Mg (400 Mg, 3 In 1 D)) was diagnosed with irritable bowel syndrome (What is irritable bowel syndrome?) and. Location: UNITED STATES , 61 years of age, weighting 204.0 lb, Patient experienced the following unwanted or unexpected effects: back pain (What is back pain?), condition aggravated. During the same period patient was treated with TELMISARTAN (View Telmisartan Review and Telmisartan Label ), OXYBUTYNIN CHLORIDE (View Oxybutynin Chloride Review and Oxybutynin Chloride Label ).

5281299-9 | Vertigo
on Nov 07, 2006 Female patient from UNITED STATES , 19 years of age, weighting 92.00 lb, was diagnosed with gastrointestinal infection, overgrowth bacterial and was treated with Xifaxan (View Usage). Patient had the following side effects: vertigo. Xifaxan dosage: 400 (200 Mg, Q12h) Oral. During the same period patient was treated with HAPARIN LOCK FLUSH (View Haparin Lock Flush Review and Haparin Lock Flush Label ), NEXIUM (40 MILLIGRAM, INJECTION) (View Nexium (40 Milligram, Injection) Review and Nexium (40 Milligram, Injection) Label ), BENADRYL (INJECTION FOR INFUSION) (View Benadryl (injection For Infusion) Review and Benadryl (injection For Infusion) Label ), LEXAPRO (20 MILLIGRAM) (View Lexapro (20 Milligram) Review and Lexapro (20 Milligram) Label ), FERROUS GLUCONATE (View Ferrous Gluconate Review and Ferrous Gluconate Label ), PHILLIPS GEL CAP (View Phillips Gel Cap Review and Phillips Gel Cap Label ), FENTANYL (View Fentanyl Review and Fentanyl Label ).

5281297-5 | Vulvovaginal Mycotic Infection
on May 18, 2005 Female patient from UNITED STATES , 19 years of age, was diagnosed with crohn's disease (What is crohn's disease?) and was treated with Xifaxan (View Usage). After Xifaxan was administered, patient had the following side effects: vulvovaginal mycotic infection. Xifaxan dosage: 200mg/bid, Oral. During the same period patient was treated with PENTASA (View Pentasa Review and Pentasa Label ).

5281296-3 | Hyperhidrosis, Throat Irritation, Throat Tightness
Patient was taking Xifaxan (View Usage). Patient experienced the following unwanted or unexpected effects: hyperhidrosis, throat irritation, throat tightness on Nov 18, 2005 from UNITED STATES Additional patient health information: Male patient , 43 years of age, weighting 208.0 lb, was diagnosed with intestinal functional disorder and. Xifaxan dosage: 400mg/tid, Oral. During the same period patient was treated with MOTILIUM (View Motilium Review and Motilium Label ), PREVACID (View Prevacid Review and Prevacid Label ), BENICAR (View Benicar Review and Benicar Label ).

5281294-X | Dehydration, Hypotension
Adverse event was reported on May 20, 2004 by a Female patient taking Xifaxan (View Usage) (Dosage: ) was diagnosed with crohn's disease (What is crohn's disease?) and. Location: UNITED STATES , 46 years of age, Patient had the following side effects: dehydration, hypotension. During the same period patient was treated with COLAZAL (View Colazal Review and Colazal Label ), FLAGYL (View Flagyl Review and Flagyl Label ).

5281291-4 | Abdominal Distension, Decreased Appetite, Dry Mouth, Headache, Nausea
on Oct 04, 2006 Male patient from UNITED STATES , 27 years of age, was diagnosed with overgrowth bacterial and was treated with Xifaxan (View Usage). After Xifaxan was administered, patient had the following side effects: abdominal distension, decreased appetite, dry mouth, headache (What is headache?), nausea (What is nausea?). Xifaxan dosage: Two Tablets (400mg) / Tid (200 Mg), Oral.

5281290-2 | Abdominal Pain, Constipation, Faeces Hard, Flatulence, Frequent Bowel Movements
on Oct 16, 2006 Female patient from UNITED STATES , 53 years of age, weighting 88.00 lb, was diagnosed with bacterial infection (What is bacterial infection?), gastric infection and was treated with Xifaxan (View Usage). Patient experienced the following unwanted or unexpected effects: abdominal pain (What is abdominal pain?), constipation (What is constipation?), faeces hard, flatulence, frequent bowel movements. Xifaxan dosage: 200mg/bid, Oral. During the same period patient was treated with KLONOPIN (View Klonopin Review and Klonopin Label ).

5281289-6 | Abdominal Pain, Diarrhoea
Patient was taking Xifaxan (View Usage). Patient had the following side effects: abdominal pain (What is abdominal pain?), diarrhoea on Aug 29, 2006 from UNITED STATES Additional patient health information: Female patient , 59 years of age, weighting 130.0 lb, was diagnosed with irritable bowel syndrome (What is irritable bowel syndrome?) and. Xifaxan dosage: 400mg/bid, Oral.